Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared BPC-157 for therapeutic use in humans or animals
Dosage Guidelines The objective of this dosing regimen is to mitigate the effects of aging and age-related diseases through a targeted "cell cleansing" approach
We build long-term relationships with our pharmacy partners to ensure treatments remain reliable, personalized, and aligned with long-term patient outcomes
Its effects stay focused on adipose tissue: AOD9604 stimulates lipolysis primarily through beta3 adrenergic receptor pathways in adipose tissue, driving the breakdown of stored triglycerides into free fatty acids
What makes this combination distinct from studying each peptide separately
